/ 2 items

#JANX↓

JANX/ 01/22/2026 · 9:19 AM

Janux Therapeutics Partners with Bristol Myers Squibb in Major Cancer Drug Deal

Janux Therapeutics announces collaboration with Bristol Myers Squibb to develop novel tumor-activated cancer therapy, with potential payments up to $850 million.

JANX/ 12/01/2025 · 5:00 PM

Janux's Prostate Cancer Drug Shows Declining Response Rates in Early Trial Data

Janux Therapeutics' (JANX) JANX007 immunotherapy disappoints with only 30% response rate in heavily pre-treated prostate cancer patients, raising concerns about efficacy.